Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions

Human-induced pluripotent stem cells (hiPSCs) have shown great potential toward practical and scientific applications. We previously reported the generation of human dental pulp stem cells using non-integrating replication-defective Sendai virus (SeVdp) vector in feeder-free culture with serum-free...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:In vitro cellular & developmental biology. Animal Ročník 56; číslo 1; s. 85 - 95
Hlavní autoři: Hamada, Atsuko, Akagi, Eri, Yamasaki, Sachiko, Nakatao, Hirotaka, Obayashi, Fumitaka, Ohtaka, Manami, Nishimura, Ken, Nakanishi, Mahito, Toratani, Shigeaki, Okamoto, Tetsuji
Médium: Journal Article
Jazyk:angličtina
Vydáno: New York Springer Science & Business Media LLC 01.01.2020
Springer US
Society for In Vitro Biology
Témata:
ISSN:1071-2690, 1543-706X, 1543-706X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Human-induced pluripotent stem cells (hiPSCs) have shown great potential toward practical and scientific applications. We previously reported the generation of human dental pulp stem cells using non-integrating replication-defective Sendai virus (SeVdp) vector in feeder-free culture with serum-free medium hESF9. This study describes the generation of hiPSCs from peripheral blood mononuclear cells to increase the donor population, while reducing biopsy invasiveness. From 6-d-old primary culture of peripheral blood mononuclear cells (PBMCs) with IL-2, hiPSCs were established using SeVdp(KOSM)302L with recombinant Laminin-511 E8 fragments under serum-free condition. The established PBMC-derived hiPSCs showed pluripotency and differentiation ability both in vivo and in vitro. In addition, we evaluated microarray data from PBMC- and dental pulp-derived hiPSCs. These hiPSCs will be beneficial for characterizing the molecular mechanisms of cellular differentiation and may provide useful substrates for developing cellular therapeutics.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1071-2690
1543-706X
1543-706X
DOI:10.1007/s11626-019-00412-w